| Patterns of onset and resolution of immune‐related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced … JS Weber, R Dummer, V de Pril, C Lebbé, FS Hodi, ... Cancer 119 (9), 1675-1682, 2013 | 481 | 2013 |
| An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital ER Bremberg, C Hising, U Nylén, H Ehrsson, S Eksborg Journal of Oncology Pharmacy Practice 12 (2), 75-81, 2006 | 79 | 2006 |
| The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy AS Boşnak, N Birand, Ö Diker, A Abdi, B Başgut Journal of Oncology Pharmacy Practice 25 (6), 1312-1320, 2019 | 60 | 2019 |
| Denosumab in hypercalcemia of malignancy: a case series A Dietzek, K Connelly, M Cotugno, S Bartel, AM McDonnell Journal of Oncology Pharmacy Practice 21 (2), 143-147, 2015 | 58 | 2015 |
| Breast subtypes and prognosis of breast cancer patients with initial bone metastasis: a population-based study D Liu, J Wu, C Lin, L Andriani, S Ding, K Shen, L Zhu Frontiers in oncology 10, 580112, 2020 | 40 | 2020 |
| Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis S Li, T So, G Tang, HY Tan, N Wang, BFL Ng, CKW Chan, ECL Yu, ... Frontiers in Oncology 10, 599073, 2020 | 34 | 2020 |
| Bone health management in prostate cancer patients receiving androgen deprivation therapy V Dhanapal, DJ Reeves Journal of Oncology Pharmacy Practice 18 (1), 84-90, 2012 | 30 | 2012 |
| Immune checkpoint inhibition for triple-negative breast cancer: current landscape and future perspectives H Yi, Y Li, Y Tan, S Fu, F Tang, X Deng Frontiers in oncology 11, 648139, 2021 | 28 | 2021 |
| Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review AM Suliman, SA Bek, MS Elkhatim, AA Husain, AY Mismar, MZS Eldean, ... Cancer Immunology, Immunotherapy 70, 935-944, 2021 | 27 | 2021 |
| Practice implications of an antimicrobial stewardship intervention in a tertiary care teaching hospital, Qatar Z Nasr, A Babiker, M Elbasheer, A Osman, S Elazzazy, KJ Wilby World Health Organization, 2019 | 26 | 2019 |
| Cognitive effects and depression associated with taxane-based chemotherapy in breast cancer survivors: a meta-analysis EY Ibrahim, I Domenicano, K Nyhan, M Elfil, SS Mougalian, B Cartmel, ... Frontiers in oncology 11, 642382, 2021 | 25 | 2021 |
| Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report S Elazzazy, AE Mohamed, A Gulied OncoTargets and therapy, 1641-1645, 2014 | 23 | 2014 |
| Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain) M Santolaya, M Aldea, J Grau, M Estrada, M Barau, A Buron, M Francesc, ... Journal of Oncology Pharmacy Practice 23 (1), 26-32, 2017 | 22 | 2017 |
| Diagnosis and management of hematological adverse events induced by immune checkpoint inhibitors: a systematic review NE Omar, KA El-Fass, AI Abushouk, N Elbaghdady, AEM Barakat, ... Frontiers in immunology 11, 531929, 2020 | 21 | 2020 |
| Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied N Kheir, A Awaisu, H Gad, S Elazzazy, F Jibril, M Gajam International journal of clinical pharmacy 37, 1180-1187, 2015 | 21 | 2015 |
| Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study SM Nasser, A Sahal, A Hamad, S Elazzazy* Journal of Oncology Pharmacy Practice, 2019 | 20 | 2019 |
| Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar NE Omar, S Elazzazy, O Abdallah, AJ Nashwan, Y Eltorki, HM Afifi, ... Journal of Oncology Pharmacy Practice 26 (5), 1086-1096, 2020 | 18 | 2020 |
| Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis P Yerram, S Kansagra, O Abdelghany Journal of Oncology Pharmacy Practice 23 (3), 179-184, 2017 | 18 | 2017 |
| Biogenic synthesis of nanoparticles and their role in the management of plant pathogenic fungi AP Ingle, A Biswas, C Vanlalveni, R Lalfakzuala, I Gupta, P Ingle, ... Microbial Nanotechnology, 135-161, 2020 | 17 | 2020 |
| Pyrotinib in the treatment of women with HER2-positive advanced breast cancer: a multicenter, prospective, real-world study L Zhang, X Wu, J Zhou, M Zhu, H Yu, Y Zhang, Y Zhao, Z Han, Y Guo, ... Frontiers in Oncology 11, 699323, 2021 | 16 | 2021 |
